Paperpal Prime Logo

Nanomedicine : Impact Factor & More

eISSN: 1748-6963pISSN: 1743-5889

Key Metrics

CiteScore
8.3
Impact Factor
5 - 10
SNIP
0.83
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Nanomedicine

Nanomedicine Journal Specifications

Overview
Publisher FUTURE MEDICINE LTD
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Nanomedicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Nanomedicine

Considerations for nanoscale drug-delivery systems for the cornea.
  • 7 Aug 2026
  • Nanomedicine (London, England)
Advances in the development and application of nanofibrous systems for intranasal drug delivery.
  • 6 Aug 2026
  • Nanomedicine (London, England)
Diagnostic and therapeutic potential of carbon nanodots for ocular disease.
  • 6 Aug 2026
  • Nanomedicine (London, England)
Bacterial extracellular vesicles: mechanisms, engineering strategies, and therapeutic potential for inflammatory bowel disease.
  • 6 Aug 2026
  • Nanomedicine (London, England)
Evolution of peptide-mediated siRNA delivery - from early design to next generation platform.
  • 1 Aug 2026
  • Nanomedicine (London, England)
Advances in carbohydrate polymer-based stimuli-responsive nanocarriers: precision strategies for overcoming multidrug resistance in targeted cancer therapy.
  • 30 Jul 2026
  • Nanomedicine (London, England)
Considerations for nanoscale drug-delivery systems for the cornea.
  • 7 Aug 2026
  • Nanomedicine (London, England)
Advances in the development and application of nanofibrous systems for intranasal drug delivery.
  • 6 Aug 2026
  • Nanomedicine (London, England)
Diagnostic and therapeutic potential of carbon nanodots for ocular disease.
  • 6 Aug 2026
  • Nanomedicine (London, England)
Bacterial extracellular vesicles: mechanisms, engineering strategies, and therapeutic potential for inflammatory bowel disease.
  • 6 Aug 2026
  • Nanomedicine (London, England)
Evolution of peptide-mediated siRNA delivery - from early design to next generation platform.
  • 1 Aug 2026
  • Nanomedicine (London, England)
Advances in carbohydrate polymer-based stimuli-responsive nanocarriers: precision strategies for overcoming multidrug resistance in targeted cancer therapy.
  • 30 Jul 2026
  • Nanomedicine (London, England)

FAQs on Nanomedicine